Exact Sciences Corp (NAS:EXAS)
$ 54.57 -0.15 (-0.27%) Market Cap: 10.10 Bil Enterprise Value: 11.91 Bil PE Ratio: 0 PB Ratio: 3.15 GF Score: 80/100

Exact Sciences Corp at UBS Genomics 2.0 and MedTech Innovations Summit Transcript

Aug 10, 2022 / 08:00PM GMT
Release Date Price: $45.13 (+4.83%)
Elizabeth Cristina Mari Garcia
UBS Investment Bank, Research Division - US Life Science Analyst

All right. Back for yet another session. All right. You got me again, Liza Garcia, UBS life science tools and diagnostics analyst. And we are super fortunate today. We have quite the team from Exact Sciences. We have got Jeff Elliott, the Chief Financial Officer; we have Jorge Garces, the Chief Science Officer; and we have Brian Baranick, the General Manager, Precision Oncology, with us today. So we would love to get started and hopefully walk through a couple of questions. All right. Welcome, guys.

Questions & Answers

Elizabeth Cristina Mari Garcia
UBS Investment Bank, Research Division - US Life Science Analyst

So given that this is kind of the genomics conference, let's start with Thrive and the early detection cancer assay. It would be great to get an update from one of you on how the team is progressing there. I know there was data presented at AACR, and then there's a plan to share some kind of exciting data at ESMO, where we'll get to see the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot